HealthCCSng vs VX1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

HealthCCSng

by Nano-X AI

VX1

by Volta Medical

AI Verdict

HealthCCSng is designed for diagnostic risk assessment, analyzing CT scans to detect and quantify coronary artery calcification for patients at risk of coronary artery disease. In contrast, VX1 provides real-time AI guidance to cardiac electrophysiologists during atrial fibrillation and atrial tachycardia ablation procedures. While both are cardiology AI tools, their distinct applications in diagnostic imaging versus interventional electrophysiology make them adjacent rather than direct competitors.

Choose HealthCCSng if…

Choose HealthCCSng if your primary goal is to proactively identify patients at risk of coronary artery disease by leveraging existing routine CT scans. This tool is ideal for automated, non-invasive screening to quantify coronary artery calcification and integrate risk assessment into population health or preventative cardiology workflows.

View HealthCCSng →

Choose VX1 if…

Choose VX1 if you are an electrophysiologist seeking real-time AI guidance during atrial fibrillation or atrial tachycardia ablation procedures. This solution is specifically designed to enhance procedural precision by identifying dispersed electrograms, aiming to standardize outcomes and reduce variability during complex cardiac interventions.

View VX1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	HealthCCSng	VX1
Pricing	Not publicly available	Contact for pricing
Deployment	Cloud-based, integrates with PACS and EMR systems	Software integrated with existing electrophysiology (EP) lab mapping and recording systems.
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

HealthCCSng

HealthCCSng (Tool A) emphasizes an automated workflow for results without human intervention and seamless integration with PACS and EMR systems, suggesting a highly streamlined and efficient user experience for its specific function. It operates as an opportunistic screening tool, integrating into existing radiology workflows with minimal direct user interaction. In contrast, VX1 (Tool B) is an interactive real-time decision support tool used during complex ablation procedures, requiring active engagement from the electrophysiologist.

Clinical Value

VX1

Both tools offer significant clinical value and are FDA-cleared. HealthCCSng (Tool A) provides broad, opportunistic risk stratification for coronary artery disease by detecting and quantifying CAC from routine CT scans, identifying a large population at risk. VX1 (Tool B), however, has published clinical validation (Ev-AIFib study) demonstrating its ability to standardize outcomes and achieve high freedom from atrial fibrillation after one year in complex ablation procedures, directly impacting treatment efficacy and reducing inter-operator variability.

Pricing & Value

HealthCCSng

Neither tool provides publicly available pricing information, making a direct comparison of cost difficult. However, HealthCCSng (Tool A) explicitly mentions having Category III CPT codes (0721T & 0722T) for service reimbursement, offering a clear pathway for financial value and revenue generation for healthcare providers. This transparency regarding reimbursement mechanisms gives Tool A an advantage in demonstrating its financial value proposition.

Enterprise Readiness

HealthCCSng

HealthCCSng (Tool A) explicitly states HIPAA compliance and is designed for cloud-based deployment with seamless integration into PACS and EMR systems, which are critical for enterprise adoption. While VX1 (Tool B) integrates with existing EP lab systems and mentions data protection, it does not explicitly state HIPAA compliance or BAA availability in the provided information.

Innovation

VX1

Both tools are innovative in their respective applications. HealthCCSng (Tool A) innovates by automating opportunistic coronary artery calcification detection from routine CT scans, leveraging existing data for widespread risk assessment. However, VX1 (Tool B) offers real-time, AI-guided decision support during complex cardiac ablation procedures, which represents a higher degree of innovation in terms of dynamic, interactive intervention in a live, high-stakes clinical setting.

Support & Docs

VX1

Volta Medical's VX1 (Tool B) explicitly provides access to a user manual and brochure on its website, indicating readily available documentation for users. In contrast, the provided information for HealthCCSng (Tool A) does not include any specific details regarding publicly accessible support resources or documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	HealthCCSng	VX1
Name	HealthCCSng	VX1
Company	Nano-X AI	Volta Medical
Description	FDA-cleared AI-powered solution that analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease.	FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
Primary Specialty	Cardiology, Radiology	Cardiology
Key Feature 1	Analyzes non-contrast, non-ECG gated chest CT scans	AI-guided real-time identification of dispersed electrograms (EGMs)
Key Feature 2	Automatically detects and quantifies coronary artery calcification (CAC)	Assists cardiologists during AFib and atrial tachycardia ablation procedures
Key Feature 3	Generates a numerical calcium score	Analyzes 3D anatomical and electrical maps of human atria

Videos

Demos, reviews, and walkthroughs featuring HealthCCSng and VX1.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does each tool specifically integrate into the existing clinical workflow of its target specialty, and what is the expected impact on physician decision-making and efficiency?

HealthCCSng seamlessly integrates with PACS and EMR systems, analyzing routine non-contrast, non-ECG gated chest CT scans to automatically detect and quantify coronary artery calcification (CAC). This automated workflow provides radiologists with device output as part of their standard workflow and makes a list of analyzed studies available for further clinical assessment by cardiologists and general practitioners, enabling proactive risk assessment for coronary artery disease without human intervention. VX1, on the other hand, integrates with existing electrophysiology (EP) lab mapping and recording systems to provide AI-guided real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. This real-time assistance aims to reduce inter-operator variability and standardize outcomes during active procedural intervention, directly assisting electrophysiologists in decision-making during complex ablations.

What is the depth of EHR integration for each tool, and how does it facilitate documentation and streamline the reporting of findings or procedural data?

HealthCCSng offers seamless integration with EMR systems, enabling timely and appropriate preventive care by automatically measuring and categorizing coronary artery calcium from routine CT scans. The system generates a numerical calcium score and categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories, which can be included in radiology reports and used to guide clinical care recommendations. VX1 integrates with existing EP recording and 3D navigation systems, providing real-time analysis of electrograms during ablation procedures. While the direct depth of EHR integration for documentation of VX1's real-time findings isn't explicitly detailed, its role in standardizing outcomes and providing real-time data suggests potential for streamlined procedural reporting within the EP lab environment.

What are the specific accuracy and sensitivity metrics reported for each tool, and how do these translate into improved clinical outcomes or diagnostic confidence?

HealthCCSng demonstrated an overall agreement of 89.46% (95% CI: [86.15%, 92.21%]) between its coronary calcium category and ground truth, as determined by experienced radiologists. This accuracy in detecting and quantifying CAC from routine CT scans helps identify patients at risk of coronary artery disease, with studies showing that patients in the highest CAC category are significantly more likely to suffer a cardiac event, thus improving diagnostic confidence and enabling early intervention. VX1's algorithms are trained on a large database of electrograms annotated by expert electrophysiologists to identify dispersed electrograms in real-time during AFib and atrial tachycardia ablation procedures. Clinical evidence from studies like RESTART indicates that AI-guided dispersion ablation with Volta's solution can lead to high freedom from arrhythmia and improved quality of life in challenging patient populations, suggesting enhanced clinical outcomes.

What is the anticipated learning curve for physicians to become proficient with each tool, and what is the expected timeframe to realize significant clinical or operational value?

HealthCCSng features an automated workflow that analyzes DICOM studies and provides results without human intervention, suggesting a relatively low learning curve for interpreting the generated CAC scores and categories. Clinical value can be realized quickly by leveraging existing CT scans to identify previously undetected patients at risk of cardiovascular events, enabling earlier diagnosis and preventive management. VX1 is designed to be simple to use and allows for a fast learning curve, as its algorithms are trained on a large database of electrograms annotated by expert electrophysiologists. It provides real-time guidance during ablation procedures, indicating immediate operational and clinical value by assisting in decision-making and aiming to standardize outcomes across operators.

What level of ongoing technical and clinical support is available for each tool, and can prospective users access customer references or case studies to evaluate real-world implementation success?

While specific details on ongoing technical and clinical support for HealthCCSng are not provided, Nano-X AI's solutions have shown tangible results in several healthcare systems, identifying high-risk patients and driving revenue for cardiology departments. Corewell Health, for instance, reported a significant increase in detecting coronary calcification after implementing HealthCCSng. For VX1, Volta Medical has created the AI for Persistent AF Care program to connect patients, caregivers, and providers with resources about AF and AI-guided treatment, and has highlighted clinical cases and trial data. Prospective users would need to contact each vendor directly for detailed information on support structures and to access comprehensive customer references or case studies.

Beyond standard compliance, what advanced security measures are implemented to protect patient data, and what audit-trail features are available to track system usage and data access?

The provided information does not explicitly detail advanced security measures beyond HIPAA compliance or specific audit-trail features for either HealthCCSng or VX1. However, in general, robust software and processes are crucial for data security in AI platforms. For HealthCCSng, as a cloud-based solution integrating with PACS and EMR systems, data security and privacy would be paramount. For VX1, which integrates with EP lab systems, ensuring the security of real-time procedural data is also critical. Physicians should inquire directly with each vendor regarding their specific security posture, data encryption methods, access controls, and the granularity of audit logs to track system usage and protect patient data.

What are the key considerations for a multi-site healthcare system looking to implement either tool across multiple facilities?

For HealthCCSng, as a cloud-based solution with seamless integration into PACS and EMR systems, key considerations for multi-site rollout would include ensuring consistent data transfer protocols, managing integration with potentially disparate EMR/PACS versions across facilities, and standardizing customizable CAC category configurations. Its automated workflow suggests scalability for analyzing routine CT scans across a large volume of studies. For VX1, which integrates with existing electrophysiology lab mapping and recording systems, multi-site implementation would require assessing compatibility with the specific EP equipment present in each lab across different facilities. Standardizing training for electrophysiologists to ensure consistent application of the AI-guided real-time identification of dispersed electrograms would also be a critical factor for successful rollout and achieving standardized outcomes across sites.